Literature DB >> 24785214

Genotype-guided dosing of vitamin K antagonists.

Elizabeth A Koller, Jeffrey C Roche, James A Rollins.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24785214     DOI： 10.1056/NEJMc1402521

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

1.  Population differences in S-warfarin pharmacokinetics among African Americans, Asians and whites: their influence on pharmacogenetic dosing algorithms.

Authors:  K Kubo; M Ohara; M Tachikawa; L H Cavallari; M T M Lee; M S Wen; M G Scordo; E A Nutescu; M A Perera; A Miyajima; N Kaneko; V Pengo; R Padrini; Y T Chen; H Takahashi
Journal:  Pharmacogenomics J       Date:  2016-08-09       Impact factor: 3.550

2.  VKORC1 and CYP2C9 polymorphisms related to adverse events in case-control cohort of anticoagulated patients.

Authors:  Silvia Misasi; Giuliana Martini; Oriana Paoletti; Stefano Calza; Giovanni Scovoli; Alessandra Marengoni; Sophie Testa; Luigi Caimi; Eleonora Marchina
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.889

Review 3.  Pharmacogenetics in the Treatment of Cardiovascular Diseases and Its Current Progress Regarding Implementation in the Clinical Routine.

Authors:  Cristina Lucía Dávila-Fajardo; Xando Díaz-Villamarín; Alba Antúnez-Rodríguez; Ana Estefanía Fernández-Gómez; Paloma García-Navas; Luis Javier Martínez-González; José Augusto Dávila-Fajardo; José Cabeza Barrera
Journal:  Genes (Basel)       Date:  2019-04-01       Impact factor: 4.096
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.